Amprius Technologies Sees Unusually Large Options Volume (NYSE:AMPX)

Amprius Technologies, Inc. (NYSE:AMPX) was the target of unusually large options trading on Tuesday. Stock investors purchased 21,890 call options on the company. This is an increase of 54% compared to the average daily volume of 14,255 call options.

Insiders Place Their Bets

In other Amprius Technologies news, Director Steven Chu sold 155,565 shares of the stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $18.50, for a total value of $2,877,952.50. Following the completion of the transaction, the director owned 127,339 shares in the company, valued at approximately $2,355,771.50. This represents a 54.99% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Wen Hsuan Hsieh sold 413,146 shares of the firm’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $18.44, for a total value of $7,618,412.24. Following the completion of the sale, the director directly owned 44,444 shares of the company’s stock, valued at approximately $819,547.36. This trade represents a 90.29% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 4,140,959 shares of company stock valued at $60,630,750 over the last 90 days. 12.90% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Alberta Investment Management Corp acquired a new stake in shares of Amprius Technologies during the 4th quarter worth about $1,001,000. Vident Advisory LLC purchased a new position in shares of Amprius Technologies during the fourth quarter valued at approximately $107,000. Summit Securities Group LLC purchased a new position in shares of Amprius Technologies during the fourth quarter valued at approximately $54,000. Numerai GP LLC boosted its position in Amprius Technologies by 29.1% during the fourth quarter. Numerai GP LLC now owns 96,209 shares of the company’s stock worth $759,000 after acquiring an additional 21,698 shares during the last quarter. Finally, Osterweis Capital Management Inc. boosted its position in Amprius Technologies by 142.6% during the fourth quarter. Osterweis Capital Management Inc. now owns 454,830 shares of the company’s stock worth $3,589,000 after acquiring an additional 267,385 shares during the last quarter. 5.04% of the stock is currently owned by hedge funds and other institutional investors.

Amprius Technologies Stock Up 4.6%

Shares of Amprius Technologies stock traded up $0.84 during trading on Thursday, hitting $19.14. 8,640,557 shares of the company were exchanged, compared to its average volume of 8,743,091. Amprius Technologies has a fifty-two week low of $1.97 and a fifty-two week high of $19.76. The firm has a 50 day moving average price of $14.79 and a 200 day moving average price of $12.46. The stock has a market capitalization of $2.62 billion, a price-to-earnings ratio of -56.30 and a beta of 2.20.

Amprius Technologies (NYSE:AMPX) last released its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.03. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.The company had revenue of $25.23 million during the quarter, compared to the consensus estimate of $22.91 million. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. Analysts predict that Amprius Technologies will post -0.45 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts recently commented on AMPX shares. Oppenheimer reiterated an “outperform” rating and issued a $17.00 price objective on shares of Amprius Technologies in a research note on Tuesday, December 23rd. Cantor Fitzgerald increased their target price on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an “overweight” rating in a report on Friday, March 6th. B. Riley Financial lifted their price target on shares of Amprius Technologies from $16.00 to $22.00 and gave the company a “buy” rating in a research report on Monday, March 9th. Weiss Ratings reissued a “sell (e+)” rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. Finally, Roth Mkm restated a “buy” rating and issued a $20.00 price target (up from $16.00) on shares of Amprius Technologies in a report on Friday, March 6th. Eight investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $19.75.

Amprius Technologies Company Profile

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.